Trial Details
COMPLETEDBasic Information
| Clinical ID | c1380 |
|---|---|
| Identifier | NCT02280629 |
| Trial Title | Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: LT-02|DRUG: Placebo|DRUG: Mesalamine |
Participant Information
| Sponsor | Dr. Falk Pharma GmbH |
|---|---|
| City | Frankfurt a.M. |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-10-01 |
|---|---|
| Primary Completion Date | 2018-10-05 |
| Completion Date | 2018-10-05 |